Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Changchun
Clinical trial register · China

Clinical Trials in Changchun, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19212 matching records held by the registry are in this view. Synced 10 Nov 2026, 03:17 UTC
19212
Studies in scope
all four open statuses
11805
Recruiting now
open to new participants
2029
Lead sponsors
across recruiting studies
Top sites
Changchun 49 Ch’ang-ch’un 1 Harbin 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca105 The First Hospital of Jilin University49 Hoffmann-La Roche31 Janssen Research & Development, LLC30 Eli Lilly and Company25 Clear sponsor filter
Site location
Changchun49 Ch’ang-ch’un1 Harbin1
All 3 locations
Target enrolment
to

Trials with a site in Changchun

49 of 19212 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
The First Hospital of Jilin University
Phase 3
148
Changchun
2026-10-28
Recruiting
The First Hospital of Jilin University
Phase 4
26
Changchun
2026-10-15
Recruiting
Vision-Language-Based Large-Scale Model for Emergency Screening
NCT07899931Acute Thoraco-Abdominal Emergency Lesions
The First Hospital of Jilin University
Not applicable
640
Changchun
2026-09-01
Recruiting
Safety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophageal Junction Cancer
NCT07790809Siewert Type II/III Gastroesophageal Junction Adenocarcinoma
The First Hospital of Jilin University
Not applicable
25
Changchun
2026-08-20
Active, closed
The First Hospital of Jilin University
Phase 2
62
Changchun
2026-07-30
By invitation
The First Hospital of Jilin University
Observational
100
Changchun
2026-07-04
Active, closed
The First Hospital of Jilin University
Phase 4
40
Changchun
2026-05-01
Not yet open
The First Hospital of Jilin University
Observational
1,424
Changchun
2026-04-30
Recruiting
The First Hospital of Jilin University
Phase 2
220
Changchun
2026-04-10
Recruiting
Tamsulosin for Early Catheter Removal After Rectal Cancer Surgery
NCT07346586Urinary Catheters, Rectal Cancer, Urinary Retention
The First Hospital of Jilin University
Not applicable
1,545
Harbin, Changchun
2026-03-18
Recruiting
The First Hospital of Jilin University
Not applicable
520
Changchun
2026-03-18
Recruiting
The First Hospital of Jilin University
Phase 2/3
212
Changchun
2026-02-23
By invitation
Innovative Probe With Laser on Radial Artery Puncture and Catheterisation in Paediatric
NCT07454005Radial Artery Catheterization, Paediatric, Ultrasound Guided
The First Hospital of Jilin University
Not applicable
408
Changchun
2026-02-11
Recruiting
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia
NCT07509086Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia (PCL)
The First Hospital of Jilin University
Phase 2
25
Changchun
2025-12-29
Recruiting
The First Hospital of Jilin University
Phase 2
30
Changchun
2025-11-01
Recruiting
The First Hospital of Jilin University
Not applicable
98
Changchun
2025-11-01
Not yet open
RATME Vs LATME in Middle and Low Rectal Cancer
NCT06105203Total Mesorectal Excision, Rectal Neoplasms, Robotic Surgical Procedures, Laparoscopy
The First Hospital of Jilin University
Not applicable
1,026
Changchun
2025-11-01
Recruiting
Association of Biomarkers and Gastric Antral Motility Index With Feeding Intolerance in Critically Ill Patients
NCT07178626Critically Ill Patients Who Are Not Allowed to Eat Orally But Can Initiate Enteral Nutrition Within 48 Hours of ICU
The First Hospital of Jilin University
Observational
160
Changchun
2025-10-20
Not yet open
The First Hospital of Jilin University
Phase 1
30
Changchun
2025-10-15
Recruiting
The PRE-VAIL Study
NCT07176624ARDS (Moderate or Severe), Prone Position, Enteral Nutrition Feeding, Intensive Care Unit (ICU) Admission
The First Hospital of Jilin University
Not applicable
259
Changchun
2025-09-14
Recruiting
Nefecon and Ambrisentan in IgA Nephropathy
NCT07030894IgA Nephropathy, Chronic Kidney Disease, Proteinuria
The First Hospital of Jilin University
Phase 4
129
Changchun
2025-09-01
Recruiting
The First Hospital of Jilin University
Not applicable
380
Changchun
2025-08-31
Recruiting
Investigation of Protein Heterogeneity in Extracellular Vesicles Derived From Different Human Blood Circulatory Regions
NCT07439965Subarachnoid Aneurysm Hemorrhage, Unruptured Intracranial Aneurysm
The First Hospital of Jilin University
Observational
120
Changchun
2025-07-29
Recruiting
The First Hospital of Jilin University
Phase 4
115
Changchun
2025-07-24
Not yet open
The First Hospital of Jilin University
Phase 2
30
Changchun
2025-06-15
Recruiting
Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial
NCT06957093Diabetes Mellitus Type 2 (T2DM), Artificial Intelligence (AI)
The First Hospital of Jilin University
Not applicable
400
Changchun
2025-06-15
By invitation
Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment
NCT06914661Breast Cancer Metastatic, Efficacy and Safety
The First Hospital of Jilin University
Observational
200
Changchun
2025-05-25
Recruiting
The First Hospital of Jilin University
Observational
500
Changchun
2025-05-21
Recruiting
The First Hospital of Jilin University
Observational
500
Changchun
2025-05-19
Recruiting
The First Hospital of Jilin University
Phase 2
25
Changchun
2025-03-08
Recruiting
The First Hospital of Jilin University
Not applicable
2,250
Changchun
2025-02-25
Recruiting
The First Hospital of Jilin University
Observational
600
Changchun
2025-02-05
Active, closed
The First Hospital of Jilin University
Observational
200
Changchun
2025-02-01
Recruiting
The First Hospital of Jilin University
Phase 2
46
Changchun
2025-01-22
Recruiting
The First Hospital of Jilin University
Not applicable
40
Changchun
2025-01-17
Recruiting
Retroperitoneal Tumor Registry
NCT07915895Retroperitoneal Neoplasms
The First Hospital of Jilin University
Observational
200
Changchun
2024-12-01
Recruiting
The First Hospital of Jilin University
Observational
90
Changchun
2024-11-25
Recruiting
The First Hospital of Jilin University
Observational
300
Changchun
2024-11-20
Recruiting
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
NCT07439991Lung Cancer (Diagnosis), Deep Vein Thrombosis (DVT), Venous Thromboembolism (VTE)
The First Hospital of Jilin University
Observational
900
Changchun
2024-11-01
Not yet open
A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China
NCT06595342Cervical Artery Stenosis, Intracranial Artery Stenosis
The First Hospital of Jilin University
Observational
60,000
Changchun
2024-10-30
Recruiting
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
NCT07119463Postoperative Hypoalbuminemia, Postoperative Complications, Gastric Cancer
The First Hospital of Jilin University
Phase 2
112
Changchun
2024-10-29
Recruiting
Hypofractionated Radiotherapy
NCT06740955Glioblastoma
The First Hospital of Jilin University
Not applicable
420
Changchun
2024-08-13
Recruiting
The First Hospital of Jilin University
Phase 1/2
35
Changchun
2024-08-13
Active, closed
The First Hospital of Jilin University
Phase 2
35
Changchun
2024-06-30
Recruiting
The First Hospital of Jilin University
Not applicable
1,084
Changchun
2024-04-29
Recruiting
The First Hospital of Jilin University
Observational
40
Changchun
2024-01-01
Not yet open
The First Hospital of Jilin University
Phase 2
45
Changchun
2023-09-01
Not yet open
The First Hospital of Jilin University
Observational
1,250
Changchun
2021-08-01
Active, closed
The First Hospital of Jilin University
Phase 2
30
Changchun
2020-03-20
Rows per page Showing 1–49 of 49
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/changchun

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,212 studies in total at the last sync on 10 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 49 of those studies with a site in Changchun that also match the filters currently applied.

How many clinical trials are recruiting in Changchun?

34 of the 49 studies on this page are recruiting new participants as of the 10 Nov 2026, 03:17 UTC sync. A further 7 have not yet opened recruitment, 5 are active but closed to new participants, and 3 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Changchun), 49 studies
PhaseStudiesRecruitingShare
Observational161032.7%
Not applicable141228.6%
Phase 211622.4%
Phase 4438.2%
Phase 1102%
Phase 1/2112%
Phase 2/3112%
Phase 3112%

Most active sponsors

Lead sponsors with the most studies (Changchun)
Lead sponsorStudiesRecruiting
The First Hospital of Jilin University4934
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.